ERA Chair Position in Rare Diseases

The Izmir Biomedicine and Genome Center (IBG, www.ibg.edu.tr ) invites applications for a position of an ERA Chair and Head of the Unit for Rare Diseases at IBG (project RareBoost#952346, H2020- WIDESPREAD-06-2020).IBG is a recently established advanced biomedical research and innovation center located in Izmir, Turkey. Its modern, state-of-the art infrastructure and facilities make IBG the largest and best-equipped public biomedical research infrastructure in Turkey. The aim of this ERA Chair’s project is to accelerate IBG’s development to become an international Center of Excellence in rare disease research and innovation.

The position will allow the candidate:

- to take a leadership role in basic and translational research into the underlying mechanisms of rare diseases;

- to establish and lead a new interdisciplinary Unit for Rare Diseases at IBG with wide autonomy and independence;

- to freely utilize laboratory space of at least 100 m2, with up to 6 positions for her/his group;

- to take advantage of IBG’s extensive basic and translational facilities and network in rare diseases;

- to interact closely with IBG’s multidisciplinary faculty;

- to obtain a 5-year contract (supported by ERA Chair grant) with the option for a subsequent permanent position, full time position.

The successful candidate is expected:

- to hold a PhD/MD or equivalent and fulfil conditions specified in European Framework for Research Careers for established (R3) or leading (R4) researcher;

- to demonstrate an international reputation based on research excellence related to rare diseases and experience in managing and leading successful research groups;

- to demonstrate the ability to secure highly-competitive research funding and the capability to compete at ERC level;

- to demonstrate the ability to cooperate creatively with multidisciplinary research groups.

Applications should be sent directly to rareboost@ibg.edu.tr and should include (i) a detailed curriculum vitae including publications, funding, patents, etc., (ii) a brief description of the current research program and accomplishments, and (iii) a letter of motivation.

Applications will be collected until August 15th 2022 and the initial review of the applications will be completed within two weeks. 3-4 selected candidates will be invited to IBG to explore the potential mutual benefits in person. One candidate will be chosen and expected to start within six months.

IBG is an equal opportunity employer and welcomes applications from all qualified candidates fulfilling the requirements specified in this announcement. The position is co-financed from EU funds (ERA Chair) and the hiring of a selected candidate is subject to the European Commission’s approval.